ARK Invest: AI-Designed Antibodies: Absci's Hair Loss Treatment


Description

A breakthrough in both biology and efficiency, Absci’s hair regrowth treatment is on track to reach Phase 2 proof of concept next year—just 3½ years from launch and at a fraction of the typical cost. Hear more from Founder and CEO Sean McClain on FYI.

View Original Source
← Back to All Articles